• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Aditya Birla Real Estate Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
500040
INE055A01016
420.1492555
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ABREL
94.33
14424.38
EPS(TTM)
Face Value()
Div & Yield %
13.69
10
0.19
 

Valiant Laboratories consolidated net profit rises 151.43% in the March 2026 quarter
May 15,2026
Net profit of Valiant Laboratories rose 151.43% to Rs 1.76 crore in the quarter ended March 2026 as against Rs 0.70 crore during the previous quarter ended March 2025. Sales rose 59.16% to Rs 91.98 crore in the quarter ended March 2026 as against Rs 57.79 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 2.20 crore during the previous year ended March 2025. Sales rose 78.04% to Rs 237.47 crore in the year ended March 2026 as against Rs 133.38 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales91.9857.79 59 237.47133.38 78
OPM %5.236.61 -2.69-3.50 -
PBDT3.971.46 172 6.810.58 1074
PBT1.050.94 12 0.77-1.51 LP
NP1.760.70 151 -3.27-2.20 -49